Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Marijn Dekkers - aVenture Research

Marijn Dekkers

AddedMar 31, 2024

UpdatedOct 12, 2026

Marijn Dekkers

Marijn Dekkers

Founder, Novalis LifeSciences

Marijn Dekkers's Career

Novalis LifeSciences

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Investment FirmHampton, VA, US

Founder

Ginkgo Bioworks

Public$1.6BBoston, MA, US

Board Member· Board

BioQ Pharma

Series D$107.8MSan Francisco, CA, US

Board Member· Board

Vizgen

Series C$136.2MCambridge, MA, US

Board Member· Board

AgBiome

Series D$252.5MTriangle (historical), NC, US

Board Member· Board

Unilever

PublicLondon, GB

Chairman

Thermo Fisher Scientific

Public$11.1BWaltham, MA, US

Chief Executive Officer

Bayer

Public$3.7BLeverkusen, North Rhine-Westphalia, DE

Chief Executive Officer

People Similar to Marijn Dekkers

Dr John RyalsBoard Member · AgBiome

Eric WardBoard Member · AgBiome

Paul Schulze-LefertCo-Founder · AgBiome

R. Alexandra KeithBoard Member · Thermo Fisher Scientific

Similar to Novalis LifeSciences

LifeSci Venture PartnersNew York City, NY, USest. 2017LifeSci Venture PartnersNew York City, NY, US · est. 2017

LifeSci Venture Partners, formed in 2017, is an early-stage investment firm in life sciences and healthcare.

Investment Firm5

BioInnovationCambridge, MA, USest. 2016BioInnovationCambridge, MA, US · est. 2016

BioInnovation LLC: A Cambridge-based life sciences firm investing in, co-founding, and nurturing early-stage ventures.

Investment Firm5

Nan Fung Life SciencesSan Francisco, CA, USest. 2017Nan Fung Life SciencesSan Francisco, CA, US · est. 2017

Nan Fung Life Sciences: A global investment platform specializing in life sciences sector.

Investment Firm30

Biospring PartnersNew York City, NY, USest. 2020Biospring PartnersNew York City, NY, US · est. 2020

Biospring Partners: A growth-stage firm investing in life sciences tech, driving industry innovation.

Investment Firm11

Leadership at Unilever

Rutger PlankenDirector and Founder, FoodServicehub

Katy WigdahlCommercial Manager

Fernando AcostaGlobal Brand President, Dove

Similar to Unilever

Colgate-PalmoliveNew York City, NY, USOral Care, Personal Care, Pet Foodest. 1806Colgate-PalmoliveNew York City, NY, US · est. 1806

Colgate-Palmolive makes oral care, personal care, home care, and pet nutrition products.

Public · $15.2M33.8k

Procter & GambleCincinnati, OH, USConsumer Goodsest. 1837Procter & GambleCincinnati, OH, US · est. 1837

Procter & Gamble, a global consumer goods corporation, manufactures and markets diverse products worldwide.

Public · $300k107k

ReckittSlough, Berkshire, GBHealth, Home Products, Hygieneest. 1999ReckittSlough, Berkshire, GB · est. 1999

British multinational, Reckitt Benckiser Group, produces and markets health, hygiene, and home products.

HenkelDüsseldorf, North Rhine-Westphalia, DEChemicals, Consumer Goodsest. 1876HenkelDüsseldorf, North Rhine-Westphalia, DE · est. 1876

German-based Henkel AG & Co. KGaA produces industrial, commercial, and consumer chemical and consumer goods globally.

Recent news

Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous LabPR Newswire · 2026

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of Its Non-Core Biosecurity BusinessPR Newswire · 2026

NeuImmune and Ginkgo Bioworks Launch Strategic Collaboration to Accelerate Precision BiologicsNeuImmune · 2025

Leadership at Ginkgo Bioworks

Reshma ShettyPresident

Austin CheHead of Strategy

Barry CantonChief Technology Officer

Similar to Ginkgo Bioworks

Prolific MachinesEmeryville, CA, USCell Manufacturingest. 2020Prolific MachinesEmeryville, CA, US · est. 2020

Prolific Machines develops a light-controlled platform that programs living cells to manufacture therapeutic proteins and other bioproducts.

Series B · $197M67

Leadership at BioQ Pharma

Mark EhlertBoard Member

Josh KrieselFounder

Similar to BioQ Pharma

QnoviaRichmond, VA, USPharmaceuticalsest. 2018QnoviaRichmond, VA, US · est. 2018

Respira Technologies: Innovating in aerosol science for efficient drug delivery and public health protection.

Series A · $22.5M8

Qatch TechnologiesDurham, NC, USBiopharma Toolsest. 2016Qatch TechnologiesDurham, NC, US · est. 2016

QATCH Technologies: Pioneering tools for early-stage injectability and manufacturability assessment in biopharma.

Angel · $766.1k4

InvenraMadison, WI, USBiologicsest. 2011InvenraMadison, WI, US · est. 2011

Invenra: A biotech company pioneering in early-stage drug discovery and next-gen biologics.

Series B · $27.2M79

BionpharmaPrinceton, NJ, USGeneric Drugsest. 2014BionpharmaPrinceton, NJ, US · est. 2014

BionPharma: Developing and commercializing affordable, quality generic drugs through effective partnerships.

Series C · $58.2M36

Leadership at Vizgen

Matt PosardBoard Member

Andrea JacksonBoard Member

Jeffrey R MoffittBoard Member

Jiang HeCo-Founder

Similar to Vizgen

Spatial GenomicsPasadena, CA, USGenomic Analysisest. 2016Spatial GenomicsPasadena, CA, US · est. 2016

Pioneering spatial analysis and comprehensive single-cell assay in intact cells and tissues.

Series A · $56M24

Leadership at AgBiome

Scott UknesCo-Founder

John RyalsCo-Founder

Alison LawtonBoard Member

Amir NashatBoard Member

Jeff DanglCo-Founder

Misti UshioBoard Member

Similar to AgBiome

Ascribe BioscienceIthaca, NY, USCrop Protectionest. 2017Ascribe BioscienceIthaca, NY, US · est. 2017

Ascribe Bioscience: Developing eco-friendly products to boost crop defenses against pathogens since 2017.

Leadership at Thermo Fisher Scientific

Ruby ChandyBoard Member

Tyler JacksBoard Member

Lars Rebien SørensenBoard Member

Scott SperlingBoard Member

Debora SparBoard Member

Marc CasperBoard Member

Similar to Thermo Fisher Scientific

Reflect ScientificOrem, UT, USAutomation Systems, Scientific Productsest. 1993Reflect ScientificOrem, UT, US · est. 1993

Reflect Scientific, Inc. is an Orem, Utah manufacturer of cryogenic liquid-nitrogen freezers, chromatography consumables, and custom automation systems.

Leadership at Bayer

Norbert BischofbergerBoard Member

Paul AchleitnerBoard Member

Wolfgang NicklBoard Member

Bill AndersonBoard Member

Rodrigo SantosBoard Member

Stefan OelrichBoard Member

Similar to Bayer

AbCellera BiologicsVancouver, British Columbia, CAAntibody Discoveryest. 2012AbCellera BiologicsVancouver, British Columbia, CA · est. 2012

Vancouver-based AbCellera Biologics researches and develops human antibodies using proprietary technology.

Public · $889M495

Shyam SankarChairman

Harry Evans SloanBoard Member

Tom KnightFounder

StrateosMenlo Park, CA, USLab Automation, Researchest. 2019

StrateosMenlo Park, CA, US · est. 2019

Strateos: A data-driven life science company advancing research efficiency through automation and robotics.

Series B · $105.8M83

CodexisRedwood City, CA, USEnzyme Developmentest. 2002CodexisRedwood City, CA, US · est. 2002

Protein engineering company delivering enzymatic solutions for RNA and pharma manufacturing.

Public · $162M248

Culture BiosciencesSan Francisco, CA, USBioreactors, Softwareest. 2016Culture BiosciencesSan Francisco, CA, US · est. 2016

Culture Biosciences: Automated bio-reactors for biotech, enhancing product development and market speed.

Series C · $101.6M104

Vizma Life SciencesDurham, NC, USAnalysis, Softwareest. 2020

Vizma Life SciencesDurham, NC, US · est. 2020

Durham-based Vizma Life Sciences innovates in molecular imaging and chemical analysis solutions.

$150k5

Rebus BiosystemsSanta Clara, CA, USAssays, Spatial Omicsest. 2006Rebus BiosystemsSanta Clara, CA, US · est. 2006

Rebus Biosystems: Providing uncompromised spatial omics with customizable assays and subcellular resolution.

Series B · $37.8M14

10x GenomicsPleasanton, CA, USGene Sequencingest. 201210x GenomicsPleasanton, CA, US · est. 2012

10x Genomics: A leading American biotech firm, innovating in gene sequencing since 2012.

Public · $242.6M448

AgrynexIthaca, NY, USBiopesticides, Crop Protectionest. 2015

AgrynexIthaca, NY, US · est. 2015

Agrynex: Providing biocidal enzymes for crop protection against soil-borne diseases.

$50k4

BioConsortiaDavis, CA, USBiofertilizers, Crop Protectionest. 2014BioConsortiaDavis, CA, US · est. 2014

BioConsortia Inc.: An agri-biotech firm enhancing fertilizer efficiency, plant growth, and crop breeding.

Series D · $67M45

Adaptive Symbiotic TechnologiesSeattle, WA, USAgricultural Productsest. 2011Adaptive Symbiotic TechnologiesSeattle, WA, US · est. 2011

Seattle-based biotech firm specializing in symbiotic plant microbes for enhanced crop yield.

Series A · $4.5M17

SandozBasel, CHest. 1886

SandozBasel, CH · est. 1886

Global leader in generic and biosimilar medicines, supplying around 1,300 products to more than 100 countries.

Public23k

CodexisRedwood City, CA, USEnzyme Developmentest. 2002CodexisRedwood City, CA, US · est. 2002

Protein engineering company delivering enzymatic solutions for RNA and pharma manufacturing.

Public · $162M248

Portal BiotechnologiesWatertown, MA, USest. 2023Portal BiotechnologiesWatertown, MA, US · est. 2023

Portal Biotechnologies is a Watertown, Massachusetts-based cell engineering and drug discovery platform company founded in 2023.

Series A · $9M

Exeltisest. 2003

Exeltisest. 2003

Pharmaceutical group developing treatments across women's and men's health.

4k

Libbs FarmaceuticaSão Paulo, BRPharmaceuticalsest. 1958Libbs FarmaceuticaSão Paulo, BR · est. 1958

Libbs, a Brazil-based pharmaceutical company, committed to health, producing innovative solutions since 1958.

Key Pharmaceuticalsest. 1985Key Pharmaceuticalsest. 1985

Australian consumer healthcare company marketing over-the-counter medicines, devices, dermocosmetics and personal care products.

51-200 employees